LOS ANGELES CAPITAL MANAGEMENT LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,615,383
+508.5%
59,291
+396.9%
0.01%
+600.0%
Q2 2023$265,487
+23.9%
11,932
+20.6%
0.00%0.0%
Q1 2023$214,326
-81.8%
9,895
-82.9%
0.00%
-83.3%
Q4 2022$1,177,899
-27.1%
57,996
-7.9%
0.01%
-25.0%
Q3 2022$1,615,000
+101.1%
62,996
+86.5%
0.01%
+100.0%
Q2 2022$803,000
+165.9%
33,782
+151.7%
0.00%
+300.0%
Q1 2022$302,000
+47.3%
13,422
+55.8%
0.00%0.0%
Q1 2021$205,000
-48.5%
8,615
-43.3%
0.00%
-50.0%
Q4 2020$398,000
-25.7%
15,200
-50.7%
0.00%0.0%
Q3 2020$536,000
-16.9%
30,820
-19.6%
0.00%
-33.3%
Q2 2020$645,000
+205.7%
38,330
+116.2%
0.00%
+200.0%
Q1 2020$211,000
+17.2%
17,730
+19.0%
0.00%0.0%
Q4 2019$180,000
+4.7%
14,900
+15.6%
0.00%0.0%
Q4 2018$172,000
-88.7%
12,893
-88.2%
0.00%
-87.5%
Q3 2018$1,527,000
+63.1%
108,887
+82.9%
0.01%
+60.0%
Q2 2018$936,000
-26.0%
59,542
-22.6%
0.01%
-28.6%
Q1 2018$1,265,000
-53.3%
76,882
-48.7%
0.01%
-53.3%
Q4 2017$2,706,000
+100.1%
149,842
+113.9%
0.02%
+87.5%
Q3 2017$1,352,000
+634.8%
70,049
+349.3%
0.01%
+700.0%
Q2 2017$184,00015,5890.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders